Literature DB >> 11354352

Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.

D A Jabs, J T Rosenbaum.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11354352     DOI: 10.1016/s0002-9394(01)00830-3

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  11 in total

1.  Treatment of inflammatory macular edema with humanized anti-CD11a antibody therapy.

Authors:  Lisa J Faia; H Nida Sen; Zhuqing Li; Steven Yeh; Keith J Wroblewski; Robert B Nussenblatt
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-01       Impact factor: 4.799

Review 2.  Standard and novel therapeutic approaches to Behçet's disease.

Authors:  Ahmet Gul
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Risk of Ocular Hypertension in Adults with Noninfectious Uveitis.

Authors:  Ebenezer Daniel; Maxwell Pistilli; Srishti Kothari; Naira Khachatryan; R Oktay Kaçmaz; Sapna S Gangaputra; H Nida Sen; Eric B Suhler; Jennifer E Thorne; C Stephen Foster; Douglas A Jabs; Robert B Nussenblatt; James T Rosenbaum; Grace A Levy-Clarke; Nirali P Bhatt; John H Kempen
Journal:  Ophthalmology       Date:  2017-04-19       Impact factor: 12.079

Review 4.  Uveitis: advances in understanding of pathogenesis and treatment.

Authors:  Russell W Read
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

Review 5.  Emerging drugs for uveitis.

Authors:  Theresa Larson; Robert B Nussenblatt; H Nida Sen
Journal:  Expert Opin Emerg Drugs       Date:  2011-01-06       Impact factor: 4.191

6.  Cataract surgery in patients with history of uveitis.

Authors:  Ujwala Baheti; Sana S Siddique; C Stephen Foster
Journal:  Saudi J Ophthalmol       Date:  2012-01

7.  Anti-tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for non-infectious uveitis.

Authors:  Robert J Barry; Mohammad O Tallouzi; Nick Bucknall; Jonathan M Mathers; Philip I Murray; Melanie J Calvert; David J Moore; Alastair K Denniston
Journal:  Cochrane Database Syst Rev       Date:  2018-12-18

Review 8.  HMBG1 as a Driver of Inflammatory and Immune Processes in the Pathogenesis of Ocular Diseases.

Authors:  Yi Liu; Guo-Bin Zhuang; Xue-Zhi Zhou
Journal:  J Ophthalmol       Date:  2018-10-24       Impact factor: 1.909

9.  Role of intravitreal triamcinolone as an adjuvant in the management of Vogt-Koyanagi-Harada disease.

Authors:  Mayur R Moreker; Sikander A Lodhi; Avinash Pathengay
Journal:  Indian J Ophthalmol       Date:  2007 Nov-Dec       Impact factor: 1.848

10.  Pharmacokinetics after Periocular Methylprednisolone Sodium Succinate Injection in Rabbit Eyes.

Authors:  Hua-Yi Lu; Rui-Qing Wang; Xin Li; Xu Li
Journal:  Evid Based Complement Alternat Med       Date:  2020-02-27       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.